These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 8901525)
1. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII. Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525 [TBL] [Abstract][Full Text] [Related]
2. The role of phospholipids and the factor VII Gla-domain in the interaction of factor VII with tissue factor. Wildgoose P; Jørgensen T; Komiyama Y; Nakagaki T; Pedersen A; Kisiel W Thromb Haemost; 1992 Jun; 67(6):679-85. PubMed ID: 1509409 [TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain. Takamiya O Thromb Haemost; 1998 Jan; 79(1):104-9. PubMed ID: 9459333 [TBL] [Abstract][Full Text] [Related]
4. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity. Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558 [TBL] [Abstract][Full Text] [Related]
5. Solution structure of the N-terminal EGF-like domain from human factor VII. Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950 [TBL] [Abstract][Full Text] [Related]
6. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Geng JP; Castellino FJ Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody (VII-M31) to bovine factor VII: a specific epitope in the gamma-carboxyglutamic acid domain. Higashi S; Kawabata S; Nishimura H; Funasaki H; Ohyama S; Miyamoto S; Funatsu A; Iwanaga S J Biochem; 1990 Oct; 108(4):654-62. PubMed ID: 1705545 [TBL] [Abstract][Full Text] [Related]
8. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII. Iino M; Foster DC; Kisiel W Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405 [TBL] [Abstract][Full Text] [Related]
9. The relative orientation of Gla and EGF domains in coagulation factor X is altered by Ca2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study. Sunnerhagen M; Olah GA; Stenflo J; Forsén S; Drakenberg T; Trewhella J Biochemistry; 1996 Sep; 35(36):11547-59. PubMed ID: 8794734 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of factor VII inhibitor found in a patient with life threatening bleeding. Kamikubo Y; Miyamoto S; Iwasa A; Ishii M; Okajima K Thromb Haemost; 2000 Jan; 83(1):60-4. PubMed ID: 10669156 [TBL] [Abstract][Full Text] [Related]
11. Use of phage display for the generation of human antibodies that neutralize factor IXa function. Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097 [TBL] [Abstract][Full Text] [Related]
12. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820 [TBL] [Abstract][Full Text] [Related]
13. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C. Geng JP; Cheng CH; Castellino FJ Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780 [TBL] [Abstract][Full Text] [Related]
14. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity. Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of recombinant human blood coagulation factor VIIa amidolytic and proteolytic activity by zinc ions. Pedersen AH; Lund-Hansen T; Komiyama Y; Petersen LC; Oestergård PB; Kisiel W Thromb Haemost; 1991 May; 65(5):528-34. PubMed ID: 1871714 [TBL] [Abstract][Full Text] [Related]
16. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor. Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729 [TBL] [Abstract][Full Text] [Related]
17. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Scandura JM; Ahmad SS; Walsh PN Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425 [TBL] [Abstract][Full Text] [Related]
18. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa. Dickinson CD; Shobe J; Ruf W J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384 [TBL] [Abstract][Full Text] [Related]
19. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity. Jin J; Perera L; Stafford D; Pedersen L J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356 [TBL] [Abstract][Full Text] [Related]
20. Coagulation factor X-binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein. Atoda H; Ishikawa M; Mizuno H; Morita T Biochemistry; 1998 Dec; 37(50):17361-70. PubMed ID: 9860851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]